Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma

Bone Marrow Transplant. 2010 Aug;45(8):1360-2. doi: 10.1038/bmt.2009.338. Epub 2009 Dec 7.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Carcinoma, Renal Cell / therapy*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Kidney Neoplasms / therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*
  • Transplantation, Homologous

Substances

  • Protein Kinase Inhibitors
  • TOR Serine-Threonine Kinases